HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Church & Dwight Personal Care Sales Advance 5% In Q1 On Oral, Skin Care

This article was originally published in The Rose Sheet

Executive Summary

Church & Dwight personal care sales, including Armkel and affiliates, rose 5% to $94.7 mil. in the first quarter, fueled largely by strong performances in the oral care and skin care categories, the firm reported in a 1sales and earnings release May 5

You may also be interested in...



C&D Personal Care Unveils Three Major Launch Initiatives For 2003

Church & Dwight's launch plan for the year includes three "strategic" initiatives in the deodorant/antiperspirant and oral care categories, marking an increase in launch activity over 2002, Personal Care and Armkel President Brad Casper said during a Feb. 10 analyst call

Arm & Hammer Complete Care Enters “All-In-One” Toothpaste Category

Church & Dwight is introducing Arm & Hammer Complete Care toothpaste as its first entry in the "all-in-one" toothpaste category, Personal Care and Armkel President Brad Casper said

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011186

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel